Doctor profile · Federal record
Dr. Laura Hay, APN
Nurse Practitioner · Family Nurse Practitioner · Reno, NV
- NPI 1891935268
- Accepts Medicare
- MIPS 83.8 / 100 · 2023
- 18 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
555 N. Arlington Avenue
Reno, NV 895034724
(775) 786-3040
fax (775) 786-1358 - Mailing address
-
640 W Moana Ln
Reno, NV 895094903
Credentials & registration
- NPI registered
- February 2009 — 17 yrs on file
- Profile last updated
- September 25, 2018
- Year of graduation
- 2008 — 18 yrs since
- Specialty taxonomy
- 363L00000X — NUCC code
- State license (1)
- Nevada #APN001075
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1891935268. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
5,342
Distinct HCPCS
10
Medicare allowed
$192,494
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 2,950 | 431 | $6 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 951 | 673 | $77 | |
17000 |
Destruction of precancer skin growth, 1 growth | 722 | 510 | $50 | |
11102 |
Biopsy of related skin growth, first growth | 243 | 214 | $83 | |
17110 |
Destruction of skin growth, 1-14 growths | 100 | 88 | $96 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 92 | 80 | $48 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 63 | 62 | $109 | |
17004 |
Destruction of precancer skin growth, 15 or more growths | 59 | 46 | $145 | |
11103 |
Biopsy of related skin growth, each additional growth | 52 | 37 | $43 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 33 | 33 | $96 |
In context: peer comparison
Among 31 peers in this city , average services per provider: 323. This provider delivers 17× the peer median.Open Payments
Industry payments received
All-time total
$2,570
Transactions
72
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Janssen Biotech, Inc. | 14 | $768.12 | |
| E.R. Squibb & Sons, L.L.C. | 6 | $348.53 | |
| Novartis Pharmaceuticals Corporation | 15 | $258.46 | |
| Lilly USA, LLC | 6 | $206.68 | |
| Amgen Inc. | 4 | $182.49 | |
| Regeneron Healthcare Solutions, Inc. | 7 | $166.95 | |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $162.85 | |
| ABBVIE INC. | 10 | $140.73 | |
| Janssen Scientific Affairs, LLC | 1 | $123.83 | |
| Arcutis Biotherapeutics, Inc. | 1 | $41.70 | |
| UCB, Inc. | 1 | $39.95 | |
| GENZYME CORPORATION | 2 | $33.42 | |
| Incyte Corporation | 1 | $29.82 | |
| PolyNovo North America LLC | 1 | $24.85 | |
| Organogenesis Inc. | 1 | $18.51 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
462
Patients
264
Total drug cost
$14,398
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ketoconazole | Generic | 81 | 54 | $1,892 |
| Triamcinolone Acetonide | Generic | 68 | 59 | $596 |
| Clobetasol Propionate | Generic | 62 | 40 | $2,287 |
| Fluorouracil | Generic | 52 | 48 | $3,446 |
| Doxycycline Hyclate | Generic | 51 | 16 | $1,976 |
| Acyclovir | Generic | 39 | 25 | $361 |
| Ciclopirox | Generic | 22 | 0 | $329 |
| Ammonium Lactate | Generic | 18 | 0 | $486 |
| Valacyclovir (Valacyclovir Hcl) | Brand | 16 | 11 | $532 |
| Betamethasone Dipropionate | Generic | 14 | 0 | $805 |
Frequently asked questions
What is Dr. Laura Hay's medical specialty?
Dr. Laura Hay practices Nurse Practitioner in Reno, NV.
Where does Dr. Laura Hay practice?
Dr. Laura Hay practices at 555 N. Arlington Avenue, Reno, NV 895034724. Office phone: 7757863040.
What is Dr. Laura Hay's NPI?
Dr. Laura Hay's National Provider Identifier (NPI) is 1891935268, issued by NPPES.
Does Dr. Laura Hay accept Medicare assignment?
Yes. Dr. Laura Hay accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Laura Hay commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.